LONDON, July 8 (UPI) -- Although marijuana is best known for bringing on the "munchies," researchers in Britain found two marijuana compounds act together as an appetite suppressant.
Dr. Steph Wright, director of research and development at GW Pharmaceuticals, said four Phase 2 clinical trials will have results by the end of the year that might help develop a drug used to treat patients suffering from "metabolic syndrome" -- a risk factor for heart disease, the Sunday Telegraph reported.